These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16352577)

  • 1. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein.
    Li XQ; Fu ZF; Alvarez R; Henderson C; Tripp RA
    J Virol; 2006 Jan; 80(1):537-40. PubMed ID: 16352577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.
    Zhang W; Choi Y; Haynes LM; Harcourt JL; Anderson LJ; Jones LP; Tripp RA
    J Virol; 2010 Jan; 84(2):1148-57. PubMed ID: 19864390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
    Harcourt JL; Karron RA; Tripp RA
    J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of respiratory syncytial virus disease in childhood.
    McNamara PS; Smyth RL
    Br Med Bull; 2002; 61():13-28. PubMed ID: 11997296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus prolifically infects N2a neuronal cells, leading to TLR4 and nucleolin protein modulations and RSV F protein co-localization with TLR4 and nucleolin.
    Yuan X; Hu T; He H; Qiu H; Wu X; Chen J; Wang M; Chen C; Huang S
    J Biomed Sci; 2018 Feb; 25(1):13. PubMed ID: 29427996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic epidemiology and immunopathology of RSV in children.
    Handforth J; Friedland JS; Sharland M
    Paediatr Respir Rev; 2000 Sep; 1(3):210-4. PubMed ID: 12531081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
    J Virol; 2016 Jan; 90(1):245-53. PubMed ID: 26468535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus.
    Hegele RG; Robinson PJ; Gonzalez S; Hogg JC
    Eur Respir J; 1993 Oct; 6(9):1324-31. PubMed ID: 8287949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
    Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
    J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease.
    Cortjens B; de Boer OJ; de Jong R; Antonis AF; Sabogal Piñeros YS; Lutter R; van Woensel JB; Bem RA
    J Pathol; 2016 Feb; 238(3):401-11. PubMed ID: 26468056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
    Chirkova T; Lin S; Oomens AGP; Gaston KA; Boyoglu-Barnum S; Meng J; Stobart CC; Cotton CU; Hartert TV; Moore ML; Ziady AG; Anderson LJ
    J Gen Virol; 2015 Sep; 96(9):2543-2556. PubMed ID: 26297201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with respiratory syncytial virus vaccines.
    Piedra PA
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway.
    Oshansky CM; Krunkosky TM; Barber J; Jones LP; Tripp RA
    Viral Immunol; 2009 Jun; 22(3):147-61. PubMed ID: 19435411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
    Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
    J Virol; 2015 Jan; 89(1):512-22. PubMed ID: 25339762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.
    Hirakawa S; Kojima T; Obata K; Okabayashi T; Yokota S; Nomura K; Obonai T; Fuchimoto J; Himi T; Tsutsumi H; Sawada N
    J Med Virol; 2013 Dec; 85(12):2141-50. PubMed ID: 24009192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.
    Shaikh FY; Cox RG; Lifland AW; Hotard AL; Williams JV; Moore ML; Santangelo PJ; Crowe JE
    mBio; 2012; 3(1):. PubMed ID: 22318318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis.
    Jeena PM; Ayannusi OE; Annamalai K; Naidoo P; Coovadia HM; Guldner P
    S Afr Med J; 2003 Apr; 93(4):291-4. PubMed ID: 12806723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.